Your browser doesn't support javascript.
loading
Sensitization Assessment of Extractables and Leachables in Pharmaceuticals: ELSIE Database Analysis.
Parris, Patricia; Whelan, Geraldine; Burild, Anders; Whritenour, Jessica; Bruen, Uma; Bercu, Joel; Callis, Courtney; Chilton, Martyn L; Graham, Jessica; Johann, Esther; Johnson, Candice; Griffin, Troy; Kohan, Martin; Martin, Elizabeth A; Masuda-Herrera, Melisa; Stanard, Brad; Cruz, Maureen T; Nagao, Lee.
Affiliation
  • Parris P; Pfizer Worldwide Research, Development and Medical, Sandwich, UK; patricia.parris@pfizer.com.
  • Whelan G; GlaxoSmithKline, Ware, UK.
  • Burild A; Novo Nordisk A/S, Safety Sciences and Imaging, Malov, Denmark.
  • Whritenour J; Pfizer Worldwide Research, Development and Medical, Groton, CT, USA.
  • Bruen U; Organon USA Inc., Jersey City, NJ, USA.
  • Bercu J; Gilead Sciences Inc., Foster City, CA, USA.
  • Callis C; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN, USA.
  • Chilton ML; Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.
  • Graham J; Genentech, Inc., South San Francisco, CA, USA.
  • Johann E; Merck KGaA, Darmstadt, Germany.
  • Johnson C; Instem, 1393 Dublin Road, Columbus, Ohio USA.
  • Griffin T; Teva Branded Pharmaceutical Products R&D, West Chester, PA, USA.
  • Kohan M; formerly of Global Sustainability, AstraZeneca, Cambridge, UK.
  • Martin EA; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Masuda-Herrera M; Gilead Sciences.
  • Stanard B; Ultragenyx Pharmaceutical Inc., Novato, CA, USA.
  • Cruz MT; Faegre Drinker Biddle & Reath LLP.
  • Nagao L; Faegre Drinker Biddle & Reath.
Article de En | MEDLINE | ID: mdl-37714567

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: PDA J Pharm Sci Technol Sujet du journal: FARMACIA / FARMACOLOGIA Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: PDA J Pharm Sci Technol Sujet du journal: FARMACIA / FARMACOLOGIA Année: 2023 Type de document: Article